J. Leikola

1.4k total citations
48 papers, 898 citations indexed

About

J. Leikola is a scholar working on Hematology, Immunology and Management of Technology and Innovation. According to data from OpenAlex, J. Leikola has authored 48 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 11 papers in Immunology and 10 papers in Management of Technology and Innovation. Recurrent topics in J. Leikola's work include Blood groups and transfusion (15 papers), Blood donation and transfusion practices (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). J. Leikola is often cited by papers focused on Blood groups and transfusion (15 papers), Blood donation and transfusion practices (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). J. Leikola collaborates with scholars based in Finland, United States and United Kingdom. J. Leikola's co-authors include W. Wagstaff, Anna Pirkola, Stig Nordling, Carl G. Gahmberg, H. A. Perkins, G. Myllylä, J. Koistinen, G. Uhlenbruck, W. Dahr and E Klemola and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

J. Leikola

45 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Leikola Finland	14	372	302	271	234	136	48	898
H. H. Gunson Nigeria	19	680 1.8×	335 1.1×	222 0.8×	165 0.7×	118 0.9×	64	1.1k
J. A. Morton United Kingdom	18	357 1.0×	163 0.5×	292 1.1×	415 1.8×	134 1.0×	29	1.1k
M J Cowan United States	11	173 0.5×	107 0.4×	231 0.9×	192 0.8×	182 1.3×	13	822
D.G. Chalmers United Kingdom	16	176 0.5×	106 0.4×	214 0.8×	282 1.2×	102 0.8×	36	911
F. Schmalzl Austria	18	424 1.1×	129 0.4×	231 0.9×	376 1.6×	80 0.6×	85	1.1k
J A Kant United States	20	225 0.6×	172 0.6×	585 2.2×	350 1.5×	225 1.7×	31	1.7k
Mia van der Hart Netherlands	17	638 1.7×	289 1.0×	170 0.6×	274 1.2×	76 0.6×	58	997
F. Stratton Nigeria	18	655 1.8×	373 1.2×	141 0.5×	166 0.7×	88 0.6×	73	904
Carl F. Hinz United States	13	308 0.8×	133 0.4×	147 0.5×	428 1.8×	60 0.4×	22	810
J CARTRON France	21	493 1.3×	446 1.5×	657 2.4×	252 1.1×	52 0.4×	65	1.3k

Countries citing papers authored by J. Leikola

Since Specialization

Citations

This map shows the geographic impact of J. Leikola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Leikola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Leikola more than expected).

Fields of papers citing papers by J. Leikola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Leikola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Leikola. The network helps show where J. Leikola may publish in the future.

Co-authorship network of co-authors of J. Leikola

This figure shows the co-authorship network connecting the top 25 collaborators of J. Leikola. A scholar is included among the top collaborators of J. Leikola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Leikola. J. Leikola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leikola, J. & W.G. van Aken. (2010). The story of Vox Sanguinis. Vox Sanguinis. 100(1). 2–9. 1 indexed citations

Leikola, J. & Marcela Contreras. (1994). Overview of Issues and Problems Facing Blood Transfusion Services. Vox Sanguinis. 67(s5). 1–3. 4 indexed citations

Reesink, Hendrik W., Roger Y. Dodd, J. Leikola, et al.. (1993). How Far Shall We Go in the Predonation Selection of Blood Donors to Safeguard Patients for Blood‐Transfusion‐Related Infections?: Editorial. Vox Sanguinis. 65(1). 1–9. 6 indexed citations

Leikola, J.. (1993). Non-remunerated donations.. PubMed. 81. 51–6. 7 indexed citations

Ebeling, Freja & J. Leikola. (1991). Post-Transfusion Hepatitis. Annals of Medicine. 23(4). 361–366.

Ebeling, Freja, R. Naukkarinen, & J. Leikola. (1991). Post‐transfusion hepatitis C in Finland. Transfusion Medicine. 1(2). 109–113. 11 indexed citations

Ebeling, Freja, R. Naukkarinen, J. Jalonen, et al.. (1991). Post‐transfusion hepatitis after open‐heart surgery in Finland—a prospective study. Transfusion Medicine. 1(2). 103–107. 13 indexed citations

Ebeling, Freja, Vesa Rasi, R. Naukkarinen, & J. Leikola. (1990). Antibodies to Hepatitis C Virus and Chronic Liver Disease among Finnish Patients with Haemophilia. Annals of Medicine. 22(6). 393–396. 10 indexed citations

Koistinen, Vesa, et al.. (1989). Common Binding Region of Complement Factors B, H and CR1 on C3b Revealed by Monoclonal Anti-C3d. PubMed. 6(4). 270–280. 55 indexed citations

10.

Leikola, J.. (1988). How Much Blood for the World?¹. Vox Sanguinis. 54(1). 1–5. 10 indexed citations

11.

Leikola, J.. (1988). Transfusion transmitted infectious agents, excluding hepatitis and human immunodeficiency viruses. Acta Anaesthesiologica Scandinavica. 32(s89). 20–25. 10 indexed citations

12.

Leikola, J.. (1987). Self-sufficiency in blood products: Background and overview. 8(3). 215–220. 3 indexed citations

13.

Leikola, J. & H. A. Perkins. (1980). Enzyme‐Linked Antiglobulin Test: An Accurate and Simple Method to Quantify Red Cell Antibodies. Transfusion. 20(2). 138–144. 58 indexed citations

14.

Koistinen, J., et al.. (1978). Gammaglobulin treatment and anti-IgA antibodies in IgA-deficient patients.. BMJ. 2(6142). 923–924. 25 indexed citations

15.

Nikoskelainen, J, J. Leikola, & E Klemola. (1974). IgM Antibodies Specific for Epstein-Barr Virus in Infectious Mononucleosis without Heterophil Antibodies. BMJ. 4(5936). 72–75. 78 indexed citations

16.

Leikola, J. & Girish N. Vyas. (1971). Human antibodies to ruminant IgM concealing the absence of IgA in man.. PubMed. 77(4). 629–38. 26 indexed citations

17.

Leikola, J., H. Hugh Fudenberg, Girish N. Vyas, & Herbert A. Perkins. (1971). Isoantibodies to Human IgM: Serologic and Immunochemical Investigations. The Journal of Immunology. 106(5). 1147–1153. 12 indexed citations

18.

Leikola, J. & Kimmo Aho. (1969). Experimentally induced mononucleosis-like heterophile antibodies in man.. PubMed. 5(1). 67–73. 11 indexed citations

19.

Leikola, J.. (1968). Studies of Agglutinability of Bovine Red Cells. International Archives of Allergy and Immunology. 33(2). 112–119. 1 indexed citations

20.

Aho, Kimmo, M Harboe, & J. Leikola. (1964). STUDIES OF THE ANTIBODY NATURE OF THE RHEUMATOID FACTOR. REACTION OF THE RHEUMATOID FACTOR WITH SHEEP ERYTHROCYTES SENSITIZED WITH HUMAN ANTI-SHEEP CELL ANTIBODIES AND WITH O RH POSITIVE CELLS SENSITIZED WITH INCOMPLETE ANTI-RH ANTIBODIES.. PubMed. 7. 403–18. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact